Clinical Trials · NCT03011008
Liraglutide as Additional Treatment to Insulin in Patients With Autoimmune Diabetes Mellitus
- Phase
- Phase 4
- Recruitment status
- Unknown
- Sponsor
- Second Xiangya Hospital of Central South University
- Enrollment
- 20
- Start date
- Jan 2017
- Locations
- 1 site, China
- Primary endpoint
- Mean amplitude of glycemic excursions (MAGE)